Premium
The use of midazolam and flumazenil in cardiovascular diagnostic and therapeutic procedures
Author(s) -
Marty J.,
Nitenberg A.
Publication year - 1990
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1990.tb03178.x
Subject(s) - midazolam , medicine , flumazenil , sedation , sedative , anesthesia , hemodynamics , intensive care medicine , benzodiazepine , receptor
Sedation is sometimes required for cardiovascular diagnostic or therapeutic procedures. Midazolarn may be proposed in these situations because of its duration of action and because of its moderate haemodynarnic effects. However, the use of midazolam implies that the standards of safety required for all anaesthetic techniques have been applied. The changes in haemodynamic data induced by the administration of midazolam must be taken into account in interpretation of the catheterisation report. At the end of investigation, flumazenil can be administered safely to reverse residual sedative effects of midazolam but its use does not exempt from normal monitoring during the recovery period.